In a recent commentary in The Scientist (June 8, 1992, page 12), Bryan Farha calls for a collective project involving scientists and religious leaders in "a grand endeavor to address the greatest existential questions on the grandest of scales: Who or what orchestrated the birth of the universe, and for what purpose?" I would think that the first step in such a process would be for scientists and religious leaders to agree on the kinds of evidence that bear on this question. If the participan
I would think that the first step in such a process would be for scientists and religious leaders to agree on the kinds of evidence that bear on this question. If the participants could overcome this initial hurdle, the rest of the program should be a piece of cake.
BRUCE GREGORY
Harvard-Smithsonian Center for Astrophysics
Cambridge, Mass.
When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.
View this Issue
In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.
In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.
In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.
Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy research.
Chief Business Officer Dr. Rob Burgess Shares How Sino Biological Is Empowering Global Biomedical Research Through Precision, Quality, and Innovation on an Exclusive Segment on Fox Business Network airing on February 1, 2026 at 4:30pm EST
Sino Biological, Inc. has announced the accelerated availability and development of critical research tools to support the global scientific community in combating NiV.
Collaboration will bring next generation orchestration and modular automation to scientists worldwide
The ranking places Refeyn among a cohort of high-growth UK technology firms spanning sectors including the life sciences, energy and sustainability, telecommunications, and digital technology.
